Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
The Dendritic Cell System and its Role in Immunogenicity
1991 • 4,733 citations
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 • 2,828 citations
Graft-versus-leukemia reactions after bone marrow transplantation
1990 • 2,781 citations
The Concept of Immunological Surveillance
2015 • 1,586 citations
Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.
1981 • 1,281 citations
Tumor Antigens Recognized by T Lymphocytes
1994 • 1,238 citations
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
1994 • 1,185 citations
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
1994 • 967 citations
Biology and clinical relevance of human natural killer cells
1990 • 930 citations
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
1990 • 926 citations
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.
1987 • 523 citations
Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.
1990 • 240 citations
Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo
1982 • 228 citations
The Human Interleukin-2 Receptor
1986 • 209 citations
A Survey of Transplantable and Transmissible Animal Tumors
1953 • 194 citations
Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses.
1994 • 172 citations
Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia
1994 • 114 citations
Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
1986 • 105 citations
Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells
1994 • 104 citations
Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+; human T cell clone by the autologous MHC class II+ melanoma
1993 • 90 citations
Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors
1987 • 82 citations
T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivo.
1991 • 66 citations
Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastases.
1990 • 63 citations
Bone marrow transplantation with interleukin-2-activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice
1990 • 61 citations
Depot Characteristics and Biodistribution of Interleukin-2 Liposomes, Importance of Route of Administration
1992 • 60 citations
Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant
1992 • 59 citations
Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.
1986 • 53 citations
Pathology of Leukemia
1969 • 52 citations
Immunotherapy of leukemia.
1992 • 31 citations
Interleukin-2 Gene Transfer into Murine Neuroblastoma Decreases Tumorigenicity and Enhances Systemic Immunity Causing Regression of Preestablished Retroperitoneal Tumors
1994 • 30 citations
Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
1966 • 26 citations
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells
1991 • 26 citations
Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.
1993 • 25 citations
Preclinical Studies of T-Cell-Mediated Immune Responses Against Autologous Tumor Cells in Patients with Acute Leukemia
1993 • 2 citations